Mereo BioPharma Group surges 8%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Mereo BioPharma Group (MREO.US) surged more than 8% during regular trading to $0.2975.

The stock is down 28.61% year to date and sits 48.75% above its 52-week low of US$0.2000.

The Nasdaq Composite is up 0.26% over the past five sessions and up 13.99% year to date.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.